Lead Scientists & Founders Advisory Board

Printer-friendly versionSend by email

CCRM staff working in each of the translational platforms can access feedback and guidance from the Lead Scientists. Bill Stanford and James Ellis are the Lead Scientists for the Cell Reprogramming & Engineering Platform. Gordon Keller and Mick Bhatia are the Lead Scientists for the Cell Manufacturing Platform and the Lead Scientist for the Biomaterials & Devices Platform is Molly Shoichet. The Chief Scientific Officer and the Lead Scientists, together with key members of CCRM form the Founders Advisory Board (FAB). The role of FAB is to provide guidance, contacts and environment scanning for CCRM activities and acts in an advisory capacity for CCRM's operations.

  • Mick Bhatia, McMaster Stem Cell and Cancer Research Institute, Hamilton
  • James Ellis, The Hospital for Sick Children Research Institute, Toronto
  • Armand Keating, University Health Network, Toronto
  • Gordon Keller, McEwen Centre for Regenerative Medicine, University Health Network, Toronto
  • Andras Nagy, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto
  • Janet Rossant, The Hospital for Sick Children Research Institute, Toronto
  • Michael Rudnicki, Ottawa Hospital Research Institute, Ottawa
  • Paul Santerre, Institute of Biomaterials & Biomedical Engineering, University of Toronto, Toronto
  • Molly Shoichet, Institute of Biomaterials & Biomedical Engineering, University of Toronto, Toronto
  • Bill Stanford, Ottawa Hospital Research Institute, Ottawa
  • Peter Zandstra, Centre for Commercialization of Regenerative Medicine, Toronto